NCT05432622View on ClinicalTrials.gov

A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

CompletedOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

April 26, 2023

Study Completion Date

July 11, 2023

Conditions
Melanoma
Trial Locations (1)

77380

Local Institution, The Woodlands

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05432622 - A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy | Biotech Hunter | Biotech Hunter